Rush University Medical Center is among the backers of Transcarent’s series C round, which pushed the company’s overall financing to $298m.

Transcarent, a US-based operator of a personalised healthcare platform for employers, secured $200m in a series C round on Tuesday from a consortium featuring Rush University Medical Center, the teaching hospital of Rush University.

Kinnevik and Human Capital co-led the round, with participation from health systems Northwell Health and Intermountain Healthcare, pharmaceutical firm Merck & Co’s Global Healthcare Innovation Fund, Ally Bridge, General Catalyst, 7wireVentures, Alta Partners, Jove Equity Partners, Threshold Ventures and GreatPoint Ventures.

Transcarent runs a healthcare platform…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).